Search

everythinglearnresearchcommunity

for

Search:↓

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Extracellular vesicles may help prevent and repair spine disc degeneration.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

UV light makes skin signs of lack of carotene and vitamin A more visible.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

Multiphoton microscopy helps understand and improve vitiligo treatments by visualizing skin cell changes.

Urologists should guide men on wellness claims, highlighting where evidence supports or contradicts marketing.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Digital health technology improves health and medication adherence in kidney transplant patients.

Combining ultrasound and microneedles improves drug delivery through the skin.

Engineered vesicles with EGF mRNA improve skin wound healing and reduce scarring.

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Alefacept showed some effectiveness for alopecia areata but needs more research.

New therapy helps treat hair loss.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

Megavoltage radiation therapy extended survival in rabbits with thymomas, especially in those weighing more than 1.57 kg.

The procedure involving seminal vesiculoscopy, TURED, and balloon dilation effectively treated a man's hematospermia and improved his dysorgasmia.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.